Johannes Kornhuber
Researcher Next ID · RN-032140
Researcher · Biochemistry, Genetics and Molecular Biology
Friedrich-Alexander-Universität Erlangen-Nürnberg
Erlangen, Germany
- Works count
- 1,521
- Citation count
- 60,847
- H-index
- 108
- i10-index
- 746
Research interests
Publications
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
JAMA Neurology · 2022 · https://doi.org/10.1001/jamaneurol.2021.5216
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study
The Lancet Neurology · 2019 · https://doi.org/10.1016/s1474-4422(19)30283-2
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Nature Genetics · 2019 · https://doi.org/10.1038/s41588-019-0358-2
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Nature Genetics · 2019 · https://doi.org/10.1038/s41588-019-0495-7
Analysis of shared heritability in common disorders of the brain
Science · 2018 · https://doi.org/10.1126/science.aap8757
Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment
Journal of Alzheimer s Disease · 2018 · https://doi.org/10.3233/jad-180325
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia
Alzheimer s & Dementia · 2018 · https://doi.org/10.1016/j.jalz.2018.10.003
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia
JAMA Psychiatry · 2017 · https://doi.org/10.1001/jamapsychiatry.2017.3391
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
JAMA · 2015 · https://doi.org/10.1001/jama.2015.4668
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
Brain · 2015 · https://doi.org/10.1093/brain/awv029
Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs
Nature Medicine · 2013 · https://doi.org/10.1038/nm.3214
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Nature Genetics · 2011 · https://doi.org/10.1038/ng.803
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
PLoS ONE · 2010 · https://doi.org/10.1371/journal.pone.0013950
Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A Novel Pharmacological Group of Drugs with Broad Clinical Applications
Cellular Physiology and Biochemistry · 2010 · https://doi.org/10.1159/000315101
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Nature Genetics · 2009 · https://doi.org/10.1038/ng.440
BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation
Journal of Neural Transmission · 2007 · https://doi.org/10.1007/s00702-007-0755-z
Therapeutic approaches to Alzheimer's disease
Brain · 2006 · https://doi.org/10.1093/brain/awl280
Current projects
No projects listed.